4-ketocarotenoids in flower petals
AssigneeBall Horticultural Company
InventorsRandal Hauptmann, Robert Eisenreich, William Eschenfeldt, Zubin Khambatta
Life of this patent
Estimating the term…
Loading patent…
AssigneeBall Horticultural Company
InventorsRandal Hauptmann, Robert Eisenreich, William Eschenfeldt, Zubin Khambatta
Estimating the term…
The formation of a carotenoid compound containing a 4-keto-β-ionene ring such as astaxanthin or canthaxanthin in flowers, and particularly in the corolla and reproductive parts of a flower of a higher plant whose flowers produce a carotenoid compound containing a β-ionene ring such as β-carotene or zeaxanthin, but otherwise do not produce astaxanthin or canthaxanthin is disclosed. One or more genes controlled by a promoter are inserted (transformed) into a higher plant. The inserted gene encodes a chimeric enzyme including (a) a carotenoid-forming enzyme that is at least a ketolase. That gene is operatively linked to (b) a plastid-directed transit peptide. Some higher plants to be transformed produce at least zeaxanthin or β-carotene in their flowers prior to transformation, whereas other plants produce little if any colored carotenoid pigments prior to transformation and are transformed with a cassette of carotenoids-forming genes. Methods of transformation and use of the transformed plants are described.
A transgenic plant or a regenerable portion thereof whose genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, (i) an N-terminal first portion comprising a plastid transit peptide portion fused to (ii) a second ketolase enzyme portion that converts a carotenoid β-ionene ring into a 4-keto-β-ionene ring, said trangene being operatively linked to a promoter that controls expression of said transgene, wherein the flower petals of a plant of the same type that is not transformed with said chimeric ketolase produce a carotenoid compound that contains a β-ionene ring having an unsubstituted 4-position, and wherein the flower petals of said transgenic plant accumulate a carotenoid compound having a 4-keto-β-ionene ring.
A transgenic plant or a regenerable portion thereof whose genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, (i) an N-terminal first portion comprising a plastid transit peptide fused to (ii) a second ketolase enzyme portion that converts a carotenoid β-ionene ring into a 4-keto-β-ionene ring, said transgene being operatively linked to a promoter that controls expression of said transgene, wherein the flower petals of a plant of the same type that is not transformed with said chimeric ketolase produce one or both of β-carotene and zeaxanthin, and wherein the flower petals of said transgenic plant accumulate a carotenoid compound having a 4-keto-β-ionene ring.
A transgenic plant or a regenerable portion thereof whose genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, (i) an N-terminal first portion comprising a plastid transit peptide fused to (ii) a second ketolase enzyme portion that converts a carotenoid β-ionene ring into a 4-keto-β-ionene ring, said transgene being operatively linked to a petal-preferred promoter that controls expression of said transgene and is from a species different from that of said plastid transit peptide, wherein the flower petals of a plant of the same type that is not transformed with said chimeric ketolase produce one or both of β-carotene and zeaxanthin, and wherein the flower petals of said transgenic plant accumulate a carotenoid compound having a 4-keto-β-ionene ring.
Dependencies are inferred from the claim text.